RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Cartesian Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$6.08−0.19 (-3.03%)
Close on Oct 19, 2026
- Market cap
- $181.55M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Cartesian Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 29, 2026 | Sep 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | May 22, 2026 | May 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2025 | Oct 21, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2025 | Oct 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 16, 2025 | SEC EDGAR |
| Current report | 8-K | May 30, 2025 | May 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2025 | Apr 29, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 8, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2025 | Jan 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 3, 2024 | Dec 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2024 | Sep 26, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 20, 2024 | Sep 23, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 20, 2024 | Aug 16, 2024 | SEC EDGAR |